## KMX: CarMax, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.69 indicates fundamental undervaluation. Caution: declining volume (49% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($35.60)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. ROSEN, THE FIRST FILING FIRM, Encourages CarMax, Inc.**
- Source: GlobeNewswire | 20251205T190856 | Bearish | Relevance: 100%
- The Rosen Law Firm is encouraging investors of CarMax, Inc. (NYSE: KMX) to secure counsel before the January 2, 2026, lead plaintiff deadline in a securities class action. The lawsuit alleges that CarMax made materially false and/or misleading statements regarding its growth prospects between June 20, 2025, and November 5, 2025. Investors who purchased CarMax securities during this period may be entitled to compensation.

**2. SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CarMax**
- Source: Newsfile | 20251205T160807 | Bearish | Relevance: 100%
- Faruqi & Faruqi, LLP is investigating potential claims against CarMax, Inc. (NYSE: KMX) on behalf of investors who suffered losses between June 20, 2025, and September 24, 2025. The lawsuit alleges CarMax misrepresented its growth prospects and failed to disclose that earlier growth was a temporary benefit from tariff speculation. Investors have until January 2, 2026, to seek the role of lead plaintiff in the federal securities class action.

**3. KMX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that CarMax, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: KLAS 8 News Now | 20251205T120924 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against CarMax, Inc. (NYSE: KMX) on behalf of investors who purchased securities between June 20, 2025, and November 5, 2025. The lawsuit alleges that CarMax overstated its growth prospects, which were temporarily boosted by customer purchases driven by speculation regarding tariffs in fiscal year 2026. Investors who suffered losses are encouraged to join the case by January 2, 2026, to potentially serve as lead plaintiff.

**4. KMX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that CarMax, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: KTLA | 20251205T120831 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against CarMax, Inc. (NYSE: KMX) and certain officers, alleging federal securities law violations. The lawsuit claims CarMax overstated growth prospects, misleading investors who purchased securities between June 20, 2025, and November 5, 2025. Investors who suffered losses during this period are encouraged to join the lead plaintiff by January 2, 2026.

**5. KMX DEADLINE ALERT: CarMax, Inc. Securities Fraud Deadline is January 2 - Investors with Losses Urged to Contact BFA Law**
- Source: KLAS 8 News Now | 20251205T100848 | Bearish | Relevance: 100%
- Bleichmar Fonti & Auld LLP has announced a class action lawsuit against CarMax, Inc. (NYSE:KMX) and its executives for alleged securities fraud, following a significant stock drop. Investors have until January 2, 2026, to seek appointment as lead plaintiff in the case, which claims the company misrepresented demand for its used cars and failed to adequately assess loan portfolios. The lawsuit stems from disappointing financial results in Q2 fiscal year 2026 and an unexpected CEO departure, both of which caused substantial drops in CarMax's stock price.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | Wedbush | $40 | $40 | 0% |
| 2025-11-12 | Barclays | $28 | $0 | 0% |
| 2025-11-10 | Morgan Stanley | $35 | $56 | -38% |
| 2025-11-07 | RBC Capital | $34 | $59 | -42% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | Wedbush | reit | Neutral |
| 2025-11-12 | Barclays | init | Underweight |
| 2025-11-10 | Morgan Stanley | down | Equal-Weight |
| 2025-11-07 | RBC Capital | down | Sector Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (-3.8%)
- Blackrock Inc.: 8.1% (+5.9%)
- State Street Corpora: 3.9% (-2.2%)
- Janus Henderson Grou: 3.4% (+1.0%)
- Diamond Hill Capital: 3.4% (-30.6%)

### Key Risks

1. Elevated short interest (10.7%): bears positioning against stock.
2. Long-term trend broken: trading 35.0% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.69 indicates undervaluation relative to growth. Balance sheet: $1.1B free cash flow. Analyst sentiment negative (5 target cuts vs 0 raises). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.8B |
| Beta | 1.29 |
| 52W Range | $30.26 - $89.47 |
| Short Interest | 10.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.69 |
| Forward P/E | 15.1 |
| Current P/E | 14.6 |
| YoY Growth | -3.2% |
| EPS Direction | FALLING |

### Technicals

MRS_20 weakening modestly (-0.9% over 5 days). Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 88th percentile. MRS_5 (-0.5%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 8.4% shows strong absolute momentum above own 20MA. Outperforming sector by 5.6pp, stock-specific strength. Below SMA200 (0.65x), long-term trend not supportive. MACD histogram positive (0.89), confirming momentum. RSI neutral at 52. Volume at 49% of 20MA suggests lack of conviction. OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.03% (CS: 88) | Strong |
| RSI_14 | 52.2 | Neutral |
| MACD Histogram | 0.89 | Bullish |
| vs SMA20 | 1.084x | Above |
| vs SMA50 | 0.961x | Below |
| vs SMA200 | 0.650x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $38.82
- **Stop Loss:** $35.60 (8.3% risk)
- **Target:** $45.26 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 310
- **Position Value:** $12,034.20
- **Portfolio %:** 12.03%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2025-12-18 (Est: $0.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.32 | $0.43 | +36.1% |
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*